Kathy A. Cronin
About
In The Last Decade
Kathy A. Cronin
20 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 953
- Immunology 747
- Genetics 524
- Molecular Biology 408
- Infectious Diseases 265
Countries citing papers authored by Kathy A. Cronin
This map shows the geographic impact of Kathy A. Cronin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy A. Cronin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy A. Cronin more than expected).
Fields of papers citing papers by Kathy A. Cronin
This network shows the impact of papers produced by Kathy A. Cronin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy A. Cronin. The network helps show where Kathy A. Cronin may publish in the future.
Co-authorship network of co-authors of Kathy A. Cronin
This figure shows the co-authorship network connecting the top 25 collaborators of Kathy A. Cronin. A scholar is included among the top collaborators of Kathy A. Cronin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy A. Cronin. Kathy A. Cronin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 5 | |
| 3 | Brief report: Phase I results using the virtual pooled registry cancer linkage system (VPR-CLS) for military cancer surveillance. | 2 |
| 4 | 159 | |
| 5 | 6 | |
| 6 | 26 | |
| 7 | 6 | |
| 8 | 60 | |
| 9 | 31 | |
| 10 | 2 | |
| 11 | 420 | |
| 12 | 215 | |
| 13 | IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response. | 8 |
| 14 | 32 | |
| 15 | Cytokine gene therapy: a new strategy for the management of cancer patients. | 21 |
| 16 | 4 | |
| 17 | 64 | |
| 18 | Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. breakdown → | 511 |
| 19 | Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. | 346 |
| 20 | 51 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.